copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Mary Thanh Hai, | FDA Mary Thanh Hai, M D serves as the Director of the Office of New Drugs (OND) in the Center for Drug Evaluation and research OND oversees the clinical and nonclinical investigations
Mary Thanh Hai, MD - DIA Global Thanh Hai is an internist endocrinologist receiving her medical degree from Georgetown University Over the past 24 years, she has held several leadership positions in FDA including Director of Division of Metabolism and Endocrinology Products from 2006-2013
FDA’s Top Cancer Regulator Declined CDER Directorship The search continues for a new leader for the FDA’s Center for Drug Evaluation and Research after George Tidmarsh resigned on Sunday Deputy Director Mike Davis is in the running, along with Mary Thanh Hai, currently head of the Office of New Drugs
ASCPT 2024 Annual Meeting She also oversees the Office of Drug Evaluation Science including the Biomarker and Clinical Outcome Assessments Qualification Programs, the Biomedical Informatics Team, the OND Research Program, and the Drug Trials Snapshot Program
FDA names Mary Thanh Hai as permanent director of Office of . . . - NewsBreak MORRISTOWN, NJ - Two men have been indicted on multiple drug charges after investigators uncovered approximately 10 kilograms of suspected cocaine concealed in a hidden vehicle compartment and seized nearly $90,000 in cash from a Paterson residence, Attorney General Matthew J Platkin, the Division of Criminal Justice, and the New Jersey State P
Mary Tran Thanh Hai | Medical Officer | FDA | OpenPayrolls Food and Drug Administration (FDA) records show Mary Tran Thanh Hai held one job between 2019 and 2023 One of the most recent records in 2023 lists a job of Medical Officer and a pay of $319,300
Mary T. Thanh Hais research This publication describes uniform definitions for cardiovascular and stroke outcomes developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the US Food and Drug